Compare MREO & FSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MREO | FSI |
|---|---|---|
| Founded | 2015 | 1991 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 67.8M |
| IPO Year | 2017 | 2000 |
| Metric | MREO | FSI |
|---|---|---|
| Price | $0.33 | $5.23 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 11.8K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 1.90% |
| EPS Growth | ★ 16.67 | 9.09 |
| EPS | N/A | ★ 0.09 |
| Revenue | $500,000.00 | ★ $15,494,325.00 |
| Revenue This Year | $6,000.20 | $4.11 |
| Revenue Next Year | $34.71 | $58.09 |
| P/E Ratio | ★ N/A | $58.56 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.20 | $3.53 |
| 52 Week High | $2.94 | $11.48 |
| Indicator | MREO | FSI |
|---|---|---|
| Relative Strength Index (RSI) | 40.25 | 42.42 |
| Support Level | $0.32 | $5.21 |
| Resistance Level | $0.42 | $5.52 |
| Average True Range (ATR) | 0.02 | 0.17 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 29.29 | 0.00 |
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.